Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
/
Veru
Create a narrative
Veru Community
NasdaqCM:VERU Community
1
Narratives
written by author
0
Comments
on narratives written by author
14
Fair Values set
on narratives written by author
Community Investing Ideas
Veru
Popular
Undervalued
Overvalued
Veru
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Aging Trends And FDA Clarity Will Unlock Opportunity
Key Takeaways Innovative therapy and robust patent protection position Veru to capture strong, long-term growth in the expanding obesity and chronic disease market. Advancing clinical progress, regulatory clarity, and potential strategic partnerships could accelerate commercialization and improve earnings visibility while reducing funding risks.
View narrative
US$25.00
FV
85.6% undervalued
intrinsic discount
23.17%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
11 days ago
author updated this narrative
Your Valuation for
VERU
VERU
Veru
Your Fair Value
US$
Current Price
US$3.60
91.0% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-126m
222m
2015
2018
2021
2024
2025
2027
2030
Revenue US$221.9m
Earnings US$32.7m
Advanced
Set Fair Value